Tumor-nervous system crosstalk in PDAC: Current landscape, challenges, and future directions.
By synthesizing emerging clinical trials targeting neurotransmitter axes, dorsal root ganglia, and neurotrophic signaling, this work provides a forward-looking roadmap for integrating precision neuro-oncology with standard regimens to simultaneously alleviate cancer pain and overcome therapeutic resistance in PDAC.